Comentario sobre: Updated recommendations for the use of Tetanus Toxoid, Reduced Diphteria Toxoid and Acellular Pertussis Vaccine (Tdap) in pregnant women and persons who have or anticipate have close contact with an infant aged < 12 months_Advisory Committee on Immunization Practices (ACIP), 2011. Centers for Disease Control and Prevention MMWR Morbility and Mortality Weekly Report October 21, 2011/60/41

dc.creatorQuian,Jorge
dc.date2011-01-01
dc.date.accessioned2023-09-25T18:35:31Z
dc.date.available2023-09-25T18:35:31Z
dc.identifierhttp://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-12492011000300009
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8838585
dc.formattext/html
dc.languagees
dc.publisherSociedad Uruguaya de Pediatría
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceArchivos de Pediatría del Uruguay v.82 n.3 2011
dc.titleComentario sobre: Updated recommendations for the use of Tetanus Toxoid, Reduced Diphteria Toxoid and Acellular Pertussis Vaccine (Tdap) in pregnant women and persons who have or anticipate have close contact with an infant aged < 12 months_Advisory Committee on Immunization Practices (ACIP), 2011. Centers for Disease Control and Prevention MMWR Morbility and Mortality Weekly Report October 21, 2011/60/41
dc.typeinfo:eu-repo/semantics/other


Este ítem pertenece a la siguiente institución